United States

Deinove SA (ALDEI.PA)

ALDEI.PA on Paris Stock Exchange

23 Aug 2017
Change (% chg)

€-0.04 (-1.98%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Deinove announces first patent in animal nutrition
Wednesday, 10 May 2017 12:30pm EDT 


Deinove FY operating loss narrows to 7.7 million euros
Friday, 31 Mar 2017 01:43am EDT 

Deinove SA : Reported on Thursday FY total operating revenues 0.8 million euros ($853,760)versus 0.5 million euros year ago . FY operating loss 7.7 million euros versus loss of 8.0 million euros year ago . FY loss for the year 6.3 million euros versus loss of 6.4 million euros year ago .Company’s net financial position amounted to 9.3 million euros at 31 December 2016.  Full Article

Deinove enters the cosmetic ingredients market with Greentech
Monday, 27 Mar 2017 12:30pm EDT 

Deinove Sa : Deinove enters the cosmetic ingredients market with Greentech with the objective of a commercial launch by end of 2018 . Partnership aims to co-develop and market new active ingredients for skin care .Ambition is to bring to market a first ingredient within 18 to 24 months.  Full Article

Deinove to list 260,000 new ordinary shares - Euronext
Monday, 5 Dec 2016 08:00am EST 

Euronext: Deinove SA to list 260,000 new ordinary shares, immediately assimilated with the existing ordinary shares, on alternext paris as of December 7 . Reason Deinove capital increase is exercise of non listed stock warrant Further company coverage: [ALDEI.PA] (Gdynia Newsroom) ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;)).  Full Article

Deinove receives 10 new patent grant agreements​​
Thursday, 18 Feb 2016 01:00pm EST 

Deinove SA:R‍eceives from US agreement for issuance of its patent PF7​.Also receives nine grants on other patent families.  Full Article

Deinove raises 10.7 mln euros in capital increase
Monday, 21 Dec 2015 02:44am EST 

Deinove SA:Total demand of about 11.8 million euros in capital increase, reflecting oversubscription rate of 128 pct of offer​‍.Full exercise of extension clause bringing issue size to 10.7 mln euros​.‍1,873,590 new shares subscribed on irreducible basis, representing about 90.9 pct of new shares to be issued​.‍After full exercise of extension clause, total gross proceeds of transaction amounts to 10.7 mln euros, issue premium included​.‍Share capital, following capital increase, to amount to 3.4 million euros​.‍Reducible subscriptions amounted to 759,178 new shares and is to be, as a result, satisfied only in part, i.e. for 497,046 new shares.  Full Article

Deinove announces capital increase of about 9.3 mln euros
Friday, 27 Nov 2015 01:41am EST 

Deinove SA:Announces capital increase, with shareholders' preferential subscription rights, of about 9.3 mln euros to finance its new momentum and industrialize its bioprocesses.Subscription parity is one new share for three existing shares.Subscription price is 4.50 euros per share.Subscription period to last from Nov. 30 to Dec. 14 inclusive.Subscription commitments are 5.5 mln euros.Says proceeds of issue will be used to give company financial means to finance acceleration of its development and industrialization of its bioprocesses, both in biofuels and biochemical.  Full Article

Deinove successfully reaches 2G bioethanol pre-industral scale in a 300-liter fermenter
Thursday, 19 Nov 2015 12:30pm EST 

Deinove SA:Deinove successfully reaches 2G bioethanol pre-industral scale in a 300-liter fermenter.Is confident in capabilities to provide a technological and economically competitive solution by 2018.  Full Article

Deinove obtains six new US patents
Thursday, 12 Nov 2015 01:30pm EST 

Deinove SA:Deinove obtains six new US patents.  Full Article

Deinove announces new R&D project with Flint Hills Resources
Tuesday, 3 Nov 2015 12:30pm EST 

Deinove SA:Announces a new research and development project in animal nutrition with Flint Hills Resources.  Full Article